New Year, New ADHD Assessment Rules in New Zealand
Attention-Deficit Hyperactivity Disorder (ADHD) patients in New Zealand will have easier access to stimulant medications from February 1, 2026, thanks to updated prescribing rules. These changes aim to streamline the assessment and diagnosis process, ensuring that more people can receive the support they need. The previous system required a written recommendation from a paediatrician or psychiatrist, or a prior diagnosis and prescription, which could be a lengthy and complex process.
Now, vocationally registered specialist GPs and nurse practitioners can initiate stimulant treatments for adults aged 18 and above who have been diagnosed with ADHD. This expansion of prescribing authority is a significant step towards improving access to care for ADHD patients across the country.
Dr. Jin Russell, Chief Clinical Advisor for Child and Youth, emphasizes that the changes are about building a robust specialist workforce and establishing pathways for safe and comprehensive assessments. While these services won't be available everywhere immediately, the goal is to provide more options for those seeking ADHD treatment.
It's important to note that ADHD assessments are intricate and time-consuming, typically requiring one to two hours and possibly spanning multiple appointments. The cost of these assessments can vary depending on the service, local funding, and the duration of the assessment and follow-up care.
The new rules allow GPs and nurse practitioners to prescribe publicly funded stimulant medications for ADHD, including methylphenidate, dexamfetamine, and lisdexamfetamine. Dr. Russell highlights the ongoing global shortages of ADHD stimulant medicines due to high demand and limited manufacturing capacity. Pharmac is actively managing supply and exploring alternative brands and treatments to meet the increased demand.
These changes mark a significant advancement in ADHD care in New Zealand, offering a more streamlined and accessible approach to diagnosis and treatment.
